Send to

Choose Destination
J Med Chem. 1990 Jun;33(6):1582-90.

Potent, low molecular weight renin inhibitors containing a C-terminal heterocycle: hydrogen bonding at the active site.

Author information

Abbott Laboratories, Cardiovascular Research Division, Abbott Park, Illinois 60064.


A series of low-nanomolar renin inhibitors containing novel C-terminal heterocycles has been designed by formally cyclizing the C-terminus of a glycol-based inhibitor to the second hydroxyl. Molecular modeling suggests that the heterocyclic oxygen hydrogen bonds as an acceptor to the flap region of renin and that the second hydroxyl in the glycol-based inhibitors behaves similarly.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center